Jazz Pharmaceuticals plc Advertising Expense
Jazz Pharmaceuticals plc (JAZZ) reported Advertising Expense of $105.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AdvertisingExpense · last filed 2026-02-24
- Jazz Pharmaceuticals plc advertising expense for fiscal 2025 was $105.60M, a 1.68% decline from fiscal 2024.
- Jazz Pharmaceuticals plc advertising expense for fiscal 2024 was $107.40M, a 16.49% increase from fiscal 2023.
- Jazz Pharmaceuticals plc advertising expense for fiscal 2023 was $92.20M, a 15.26% decline from fiscal 2022.
- Jazz Pharmaceuticals plc advertising expense for fiscal 2022 was $108.80M, a 32.63% decline from fiscal 2021.
| Period end | Advertising Expense 12 month | Advertising Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | $105.60M 10-K · filed 2026-02-24 | |
| 2024-12-31 | $107.40M 10-K · filed 2026-02-24 | |
| 2023-12-31 | $92.20M 10-K · filed 2026-02-24 | |
| 2022-12-31 | $108.80M 10-K · filed 2025-02-26 | |
| 2021-12-31 | $161.50M 10-K · filed 2024-02-28 | |
| 2020-12-31 | $99.60M 10-K · filed 2023-03-01 | |
| 2019-12-31 | $65.40M 10-K · filed 2022-03-01 | |
| 2018-12-31 | $37.40M 10-K · filed 2021-02-23 | |
| 2017-12-31 | $36.60M 10-K · filed 2020-02-25 | |
| 2016-12-31 | $29.50M 10-K · filed 2019-02-26 | |
| 2015-12-31 | $27.90M 10-K · filed 2018-02-27 | $4.20M 10-K · filed 2016-02-23 |
| 2014-12-31 | $25.70M 10-K · filed 2017-02-28 | $1.00M 10-K · filed 2015-02-24 |
| 2013-12-31 | $1.00M 10-K · filed 2016-02-23 | |
| 2012-12-31 | $700.00K 10-K · filed 2015-02-24 | |
| 2011-12-31 | $1.00M 10-K · filed 2014-02-25 | |
| 2010-12-31 | $1.60M 10-K · filed 2013-02-26 | |
| 2009-12-31 | $400.00K 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |